Dr. Nazar Al Bustani | Your smile is our cure

With over 19 years of distinguished experience in Adult Cardiology and Interventional Cardiology, Dr. Nazar Al Bustani is a recognized leader in the diagnosis and treatment of complex cardiovascular disease, particularly in high-risk coronary interventions. His clinical precision, academic excellence, and pioneering work have earned him a reputation as one of the region’s foremost cardiac specialists.

Dr. Al Bustani received his Internal Medicine training at the University of British Columbia, Vancouver, followed by fellowships in Adult Cardiology at the University of Calgary and Interventional Cardiology at the University of Western Ontario. He holds dual board certifications from the Royal College of Physicians and Surgeons of Canada in Internal Medicine and Cardiology.

Internationally credentialed, he is a Fellow of the American College of Cardiology (FACC) and the Society for Cardiovascular Angiography and Interventions (FSCAI) — reflecting his expertise in cutting-edge interventional techniques and dedication to advancing global standards of care.

Throughout his career, Dr. Al Bustani has played an instrumental role in transforming cardiac care in the UAE. He served as Director of the Cardiac Catheterization Laboratory at Sheikh Khalifa Medical City (SKMC) for a decade, where he led the institution to achieve the first Level 4 Chest Pain Center Accreditation with Primary Angioplasty outside the United States in 2011 — a landmark achievement in the region’s healthcare history.

In addition to his clinical work, Dr. Al Bustani has held prominent leadership roles, including:

• Chairman, Corporate Clinical Consent Committee at SEHA (5 years)
• National Research Coordinator, GCC Acute Coronary Syndrome Registry
• Co-author, multiple peer-reviewed cardiovascular research publications

Core Clinical Expertise

Clinical Cardiology:

• Comprehensive prevention strategies for atherosclerotic disease
• Management of valvular heart disease (aortic and mitral) and recommendation for percutaneous structural heart disease interventions if applicable
• Management of acute and chronic coronary syndromes
• Diagnosis and treatment of familial and acquired dyslipidaemias
• Cardiovascular risk assessment prior to non-cardiac surgery
• Acute and chronic heart failure (systolic and diastolic forms)
• Management of post-PCI patients and complex cardiac conditions
• Sports cardiology and cardiovascular care in athletes and interest in aviation cardiology and aviation medicine.
• Advanced management of atrial fibrillation and arrhythmias
• Oversight of antiplatelet, anticoagulation in cardiac patients.
• Management and follow up of patients on biologic therapy

Non-Invasive Diagnostics & Monitoring:

• Advanced ECG stress testing
• 24–48-hour Holter monitoring and 14-day event monitoring
• Ambulatory blood pressure monitoring interpretation

Cardiac Imaging:

• Transthoracic and stress echocardiography interpretation
• Coronary calcium scoring and CT angiography (with radiology)
• Expert analysis of invasive coronary angiography

Interventional Cardiology:

• Diagnostic and therapeutic cardiac catheterization (left and right)
• Complex coronary interventions including:
  • Chronic total occlusion (CTO) revascularization
  • Calcium plaque modification techniques (rotablation, lithotripsy)
  • Multi-vessel PCI and intermediate lesion assessment
• Invasive coronary imaging and intra-coronary arteries pressure measurements (IVUS, OCT, pressure wire)

Professional Affiliations

• Fellow, Royal College of Physicians and Surgeons of Canada
• Fellow, American College of Cardiology
• Fellow, Society for Cardiovascular Angiography and Interventions

Legacy and Impact

Dr. Al Bustani’s contributions extend beyond clinical excellence to system-level innovation and medical governance. His work has helped set new benchmarks in interventional cardiology, fostered regional collaboration through multinational research, and shaped healthcare policy and patient safety through leadership roles in clinical service line leadership and chairing the corporate consent committee in SEHA